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ABSTRACT 
 
Background: 
Women and small men treated by haemodialysis (HD) have reduced survival. This 
may be due to the practice of using total body water (V) as the normalising factor for 
dialysis dosing. Our aim in this study was to explore the equivalent dialysis dose that 
would be delivered using alternative scaling parameters corresponding to the current 
recommended minimum Kt/V target of 1.2. 
 
Study Design: 
Prospective, cross-sectional study 
 
Setting and Participants: 
1500 HD patients on thrice weekly schedule were recruited across five different 
centres.  
 
Predictors: 
Age, sex, weight, ethnicity, comorbidity level and employment status 
 
Outcomes: 
Kt was estimated by multiplying V by 1.2. Kt/BSA, Kt/REE, Kt/TEE and Kt/nPCR 
equivalent to a target Kt/V of 1.2 were then estimated by dividing Kt by the respective 
parameters. 
 
Measurements: 
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Anthropometric and HD adequacy details were obtained from direct measurements 
and medical records of patients. Body surface area (BSA) was estimated using 
Haycock formula. Resting energy expenditure (REE) was estimated using a novel 
validated equation. Total energy expenditure (TEE) was calculated from physical 
activity data obtained using Recent Physical Activity Questionnaire. Normalised 
Protein Catabolic Rate (nPCR) was estimated using standard formula. 
 
Results: 
Mean BSA was 1.87 m2, mean REE 1545 kcal/day, mean TEE 1841 kcal/day and 
mean nPCR 1.03 g/kg/day. For Kt/V of 1.2, there was a wide range of equivalent 
doses expressed as Kt/BSA, Kt/REE, Kt/TEE and Kt/nPCR. The mean equivalent 
dose was lower in women for all 4 parameters (p<0.001). Small men would also 
receive lower doses compared to larger men. Younger patients, those with low 
comorbidity, those employed and those of South Asian ethnicity would receive 
significantly lower dialysis doses with current practice. 
 
Limitations: 
Cross-sectional study and the physical activity data has been collected by an activity 
questionnaire 
 
Conclusion: 
Our data suggest that current dosing practices risk under-dialysis in women and men 
of lower body size and in specific subgroups of patients. Using BSA, REE or TEE 
based dialysis prescription would result in higher dose delivery in these patients. 
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INTRODUCTION 
 
One of the major objectives of dialysis is to remove metabolic waste products derived 
from nitrogen protein metabolism that accumulate in patients with chronic kidney 
failure. Hence, it has been suggested that minimum dialysis requirement should relate 
to the rate of metabolic waste production and could be based on factors which reflect 
the metabolic activity. However haemodialysis (HD) adequacy is currently measured 
by a dimensionless parameter Kt/V, where K is dialyser urea clearance, t is the 
dialysis time and V is the urea distribution volume (or Watson Volume) equating to 
total body water 1. V is linearly related to body weight such that smaller individuals 
will require relatively less dialysis dose compared to their larger counterparts to 
achieve the same Kt/V target. However, the relative concentration of metabolic 
wastes per unit of body weight may be higher in small individuals 2 as the ratio of 
lean muscle mass and visceral organs is relatively higher compared to body fat 3 and 
hence, they risk being under-dialysed in relation to their metabolic needs. 
 
A subgroup analysis of HEMO study suggested that women had a survival benefit 
when given higher dialysis doses 4. Others have also demonstrated an inverse 
relationship with mortality and body size in HD patients 5-8. There are a number of 
possible explanations for this phenomenon one of which may be the prescription of 
haemodialysis based on V rather than on the patient’s metabolic need. A number of 
alternate parameters for scaling dialysis dose, which better reflect the metabolic 
activity, have been suggested 9-11. 
 
6 
 
Body surface area (BSA) has been proposed as an alternative for scaling dialysis dose 
as normalising the dose based on BSA will provide more dialysis for women than 
when using Kt/V 12. 
Resting energy expenditure (REE) is the sum total of all metabolic activities at rest 
and as such may reflect the rate of metabolic waste production. Physical activity 
increases the urea generation rate in haemodialysis patients 13 and as such, may 
increase dialysis requirements. Total Energy Expenditure (TEE) encompasses both 
REE and energy expenditure from physical activity and hence, may reflect total 
metabolic waste production. Our aim in this study was to explore the equivalent 
dialysis dose that would be delivered using the above parameters for scaling 
corresponding to the current recommended minimum Kt/V target of 1.2. We also 
aimed to identify patient characteristics that would be associated with risk of sub-
optimal delivered dialysis doses with current dosing practice. 
 
SUBJECTS AND METHODS 
 
Ethical Review 
The study was approved by the North Wales Regional Ethics Committee. All subjects 
gave informed written consent to take part. 
 
Subjects 
Chronic adult HD patients older than 18 years and with dialysis vintage greater than 3 
months were recruited from the participating renal units. Exclusion criteria included 
patients dialysing for other than thrice weekly frequency, those with amputated limbs 
and those with no capacity to consent. Study information sheet, consent forms and 
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questionnaires were translated into Bengali and Urdu to facilitate data collection from 
non-English speaking patients in the participating units.  
 
Study Protocol 
Data collection 
  The following data were collected from each patient. 
1. Demographic data including age, sex, dialysis vintage, employment status 
2. Anthropometric data including height and weight were collected by direct 
measurement pre- and post-dialysis. Pre-dialysis weight was used to estimate 
Watson Volume (V). 
3. Comorbidity data was collected by using a self-report questionnaire 14. This 
scale is based on self-reporting of the presence and severity (grade 1-3) of 7 
potential comorbidities - arthritis, cancer, diabetes, heart disease, lung disease, 
liver disease, and stroke. The maximum score is 21. High comorbidity is 
designated as a composite self-report comorbidity score (CSCS) > 3. 
4. Routine pre- and post-dialysis biochemistry and haematology results were 
obtained from the local pathology system. Single-pool Kt/V (spKt/V) was 
calculated using Daugirdas formula 15.  
5. Physical activity data was obtained through Recent Physical Activity 
Questionnaire (RPAQ). RPAQ enquires about activities performed at home, 
work and leisure time and also the time spent on each activity in the preceding 
4 weeks. It has been validated against doubly labelled water technique in 
general population 16 and has been shown to be a reliable tool for estimation of 
energy expenditure in CKD patients 17. 
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Estimation of Alternative Scaling Parameters  
 Body surface area (BSA) using the Haycock formula 18 and Watson Volume (V) 1 
were derived from these measurements. 
 
Normalised protein catabolic rate (nPCR) was estimated using the below formula. 
nPCR = 5.42 * G/V + 0.17 
where G is the urea generation rate and V is the total body water. 
 
Resting Energy Expenditure (REE) was estimated from a newer predictive equation 
which was derived and validated in a cohort of HD patients 19. This disease-specific 
equation was found to be at least, if not more, accurate as previous equations derived 
from non-dialysis populations but associated with less bias. The newer equation is 
given below. 
 
REE = -2.497 * Age(years) * Factorage + 0.011 * Height2.023(cm) + 83.573 * 
Weight0.6291(kg) + 68.171 * Factorsex 
 
where Factorage is 0 if age <65 and 1 if ≥65 and Factorsex is 0 if female and 1 if male 
 
Physical activity data - Each reported activity was assigned a Metabolic Equivalent of 
Task (MET) value as per the Compendium of Physical Activities20. Sleep time per 
day was assumed to be 8 hours and any unreported time during the day was assumed 
as the time performing light activities at home as per the published literature17. The 
total daily MET was calculated by summation of each individual MET values from 
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the activities. A Mean daily MET value was then calculated by dividing the total daily 
MET by 24 hours17. 
 
Total Energy Expenditure (TEE) was estimated from the following equation. 
  TEE = REE * Mean Daily MET 
 
Scaling of Dialysis dose 
KDOQI guidelines recommend a minimum spKt/V of 1.2 per dialysis session for 
thrice-weekly schedule. Hence, in order to compare minimum dialysis targets using 
alternative scaling parameters, Kt was calculated as below. 
Kt = 1.2 * V 
Hypothetical target values of Kt/nPCR, Kt/BSA, Kt/REE and Kt/TEE for each patient 
were calculated by dividing Kt by the observed value for each parameter. 
 
Statistics 
Statistical analysis was carried out using SPSS ® version 19 (SPSS Software, IBM 
Corporation, New York, USA). Normally distributed data are presented as mean ± SD. 
The significance of differences between means was determined by Student’s t-test. 
The significance of differences between multiple group means was assessed by 
ANOVA with differences between individual groups being assessed using the post-
hoc Bonferroni correction for multiple analyses, with p-value of <0.05 being assumed 
to indicate statistical significance. Multivariable regression models to examine 
predictors of Kt/TEE were developed using forward stepwise linear regression. The 
variables used in the model were age, sex, employment status, ethnicity, body weight 
and comorbidity score. Ethnicity was deployed as a categorical variable as belonging 
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to South Asian ethnic origin or not and Black ethnic origin or not. A p-value of 0.05 
was set as threshold for entry to and 0.10 for exit from the model. Collinearity testing 
was carried out after every step change in the variable list in the regression model and 
variables with only low variance inflation factor (<10) were included. Concurrent 
models were implemented in SPSS using unstandardized and standardized variables. 
Standardization of the variables was carried out by subtracting the mean from the 
each individual value and dividing by the standard deviation of the variable. A p-
value of <0.05 was assumed to indicate statistical significance. 
 
RESULTS 
 
A total of 1500 patients (910 men and 590 women) were recruited. Their main 
demographic, biochemical and dialysis characteristics are set out in Table 1. Women 
were slightly younger, a higher proportion of them classified themselves as black, and 
fewer classified themselves as employed. All body size parameters were significantly 
greater in men than women. Men had slightly higher serum urea and haemoglobin 
levels compared to women.  Watson Volume, BSA, REE, mean daily METs, PAEE 
and TEE were all significantly lower in women than men. 
 
Table 2 reports the metabolically normalised dialysis doses mean (Kt/BSA, Kt/REE, 
Kt/TEE and Kt/nPCR) values equivalent to a Kt/V of 1.2. There were large gender 
differences.  The equivalent dose expressed as Kt was markedly less in females than 
males (38,700 ± 5,900 vs. 49,300 ± 7,900 ml; p < 0.001). There were also marked 
gender differences in the metabolically normalised parameters. Kt/BSA was 21,900 ± 
200 ml/m2 for women and 25,400 ± 1,200 ml/m2 for men (p < 0.001). For Kt/REE 
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these were 27.18 ± 1.87 ml/kcal for women and 30.34 ± 1.25 ml/kcal for men (p < 
0.001) and for Kt/TEE, 23.36 ± 2.60 ml/kcal for women and 25.60 ± 2.73 ml/kcal for 
men (p < 0.001). 
 
There were also marked differences in these parameters with respect to body size.  
Table 2 shows the influence of the body weight (expressed in quartiles).  For each 
parameter there was a significant difference between the means across the quartiles as 
judged by one-way ANOVA. Smaller patients received a much lower overall dose 
expressed in terms of Kt. The effects of body size on target dose expressed in terms of 
the metabolically normalised parameters studied were similar though of lesser 
magnitude. 
 
Patient age also influenced these parameters (Table 2).  For Kt there was a significant 
reduction across age quartiles by ANOVA. The magnitude of the reduction was 
smaller for Kt/BSA but still significant. However both Kt/REE and Kt/TEE increased 
with increasing age, suggesting a need for higher dialysis doses, by these criteria, in 
the younger age groups.  
 
Table 2 also shows the differences between these parameters with respect to ethnicity.  
In general the equivalent dose for South Asians was lower than that for Blacks which 
was lower than that for Whites. For Kt, Kt/REE, Kt/TEE there was a significant 
difference in means between ethnic groups by one-way ANOVA. For Kt/BSA the 
differences were not significantly different. These findings suggest ethnic differences 
in dialysis requirement, with relatively higher doses being required in the South Asian 
group, though it should be emphasized that this is based on differences in body size 
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characteristics and estimated physical activity, rather than any possible ethnic 
differences in energy metabolism. 
 
Patients with high comorbidity (CSCS >3) had slightly higher Kt/REE and Kt/TEE 
levels than their counterparts with lower comorbidity, though values of Kt/BSA were 
slightly lower (Table 2). Values of Kt/REE and Kt/TEE were consistently higher in 
those with arthritis, cancer, diabetes and heart disease than in those without these 
conditions. This implies that patients without comorbidities need higher dialysis doses 
according to these criteria, though again, these findings, based mainly on body size 
and physical activity, do not take into account potential differences in energy 
metabolism which may be associated with the specific comorbidities.  
 
Patients in employment had lower levels of Kt/TEE than those not employed, though 
levels of both Kt and Kt/BSA were higher (Table 2). This reflects the significantly 
greater weight (79.4 ± 18.4 vs. 74.7 ± 18.2 kg; p < 0.001) and physical activity energy 
expenditure (707 ± 339 vs. 242 ± 124 kcal/day; p < 0.001) of employed individuals. 
 
We also estimated Kt/nPCR and examined the relationships amongst different 
variables as shown in Table 2. Kt/nPCR was found to be significantly lower in 
women (40200 ± 12900 vs. 51100 ± 15700 ml/g/kg/day, p <0.001) and in those with 
lower comorbidity (46100 ± 15100 vs. 48500 ± 16400 ml/g/kg/day, p = 0.008). 
Kt/nPCR was also the lowest in those in the first weight quartile compared to the rest 
of the quartile groups with significant difference noted between the means across the 
quartiles using One-way ANOVA (p <0.001). There was no significant difference 
noted in the dose that would be delivered using Kt/nPCR in employed people 
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compared to unemployed (47400 ± 14500 vs. 46700 ± 15700 ml/g/kg/day, p = 0.604), 
in patients of different ethnicity or across age quartiles using One-way ANOVA. 
 
Given the major influence of gender on these parameters we examined the within 
gender differences in relation to body weight, age, ethnicity, comorbidity and 
employment status.  Figure 1 depicts the effect of weight on these parameters. It can 
be seen that gender has a major effect on these parameters with females having much 
lower levels of all four parameters i.e. Kt, Kt/BSA, Kt/REE and Kt/TEE. Smaller 
males have significantly lower levels for all parameters than larger males whilst for 
women there is little additional effect of weight on parameter value. This implies that 
females have a requirement for a greater dialysis dose – and that this overrides any 
effect of weight, whilst smaller males require a greater relative dose than larger males. 
The effect of age, ethnicity, comorbidity, and employment status on Kt/TEE is shown 
in Figure 2 – chosen since the findings were most consistent for this parameter.  In 
both males and females Kt/TEE was lower for younger patients, for those with low 
comorbidity, and for those in employment.  In males, there seemed little influence of 
ethnic group on Kt/TEE, whereas in South Asian females Kt/TEE was slightly but 
significantly lower than in other females  (24.17 ± 2.70 vs. 24.93 ± 2.94 ml/kcal; p < 
0.001). In linear regression models (Table 3), age, sex, weight and South Asian 
ethnicity were found to be independent predictors of Kt/BSA and Kt/REE. In addition 
to these variables, employment status was also found to be an independent predictor 
in the model with Kt/TEE as the dependant variable. In the model with Kt/nPCR as 
the dependent variable, sex, weight and South Asian ethnicity were found to be 
independent predictors. 
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DISCUSSION 
This study aimed to explore the minimum dialysis dose corresponding to current 
recommended Kt/V target that would be delivered using some of the alternative 
scaling parameters and also to identify the characteristics of patients who are at risk of 
under-dialysis with current dosing practice. We found that the predicted minimum 
delivered dialysis dose would be significantly lower in women compared to men if 
any of the three parameters – BSA, REE or TEE – are used though they all would 
have had identical Kt/V sessional values. Small women would have received lower 
doses compared to larger women if Kt/BSA was used. However, small men would 
have received significantly lower doses compared to their larger male counterparts 
irrespective of whatever the scaling parameter was used. Besides gender, younger age, 
employment, South Asian ethnicity and comorbidity status also have an impact on 
dosing based on these metabolic factors. 
 
There has been an ongoing debate as to how best adjust haemodialysis sessional 
dosing for individual patients. Some authors have argued that Kt/V is the best 
parameter to make adjustments, while others have refuted it 21, 22. Daugirdas et al have 
shown that BSA-based dialysis dosing will result in higher delivered dialysis doses to 
women and small men 23. A recent study has also shown a better relationship with 
survival for the BSA-based dosing compared to current practice 24. On the other hand, 
Morton and Singer have argued that the dialysis dose should be based on metabolic 
rate because of the non-linear correlation between body mass and metabolic rate 25. 
We have previously reported that women have relatively higher urea generation rate 
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and TEE is an independent predictor of urea generation rate 13. This would mean that 
TEE could also be considered a potential scaling parameter for dialysis dosing. The 
pros and cons of some of these proposed parameters for scaling dialysis dose have 
been discussed previously 9. 
 
Our study demonstrates that with V-based dosing, women of all body sizes are at risk 
of under-dialysis compared to similar-sized men if equivalent doses are estimated 
using alternate metabolic parameters. This shows that V-based dosing targets need to 
be gender-specific unlike current recommendations. We also found that smaller 
individuals, both women and men, would receive significantly lower dialysis dose 
with BSA-based dosing compared to their larger counterparts as per the current 
minimum dialysis dose target. This implies that V-based dosing targets also need to 
be body-size specific. Alternately, using parameters such as BSA, REE or TEE may 
inherently adjust for these gender and body size differences thus negating the 
difficulty of having multiple dose target thresholds. 
 
We also explored the use of nPCR as a scaling parameter, and found that for an 
identical target Kt/V, Kt/nPCR was lower in women, in those in the lowest weight 
quartile and in those with low comorbidity. This is not dissimilar to the other three 
parameters we have investigated. Use of Kt/nPCR though has the disadvantage of 
only being available post-hoc following peri-dialytic blood sampling, so though it 
may have utility in assessing delivered dose, it may be of limited value in dialysis 
prescription. 
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We also identified other possible patient characteristics that may be associated with 
risk of under-dialysis. Younger patients, those with low comorbidity and those who 
were employed would receive lower doses compared to their counterparts irrespective 
of whatever metabolic parameter was used for comparison. Patients of South Asian 
ethnicity are also found to be at risk of under-dialysis if REE or TEE were considered 
as scaling parameters. Bioimpedance studies have suggested differences in body 
composition, particularly muscle mass, in South Asians compared to Whites and 
Blacks 26. However, these subgroup differences are likely to be secondary to the 
differences in body weight, and physical activity levels rather than a direct effect of 
these characteristics on metabolic needs. Given this relationship between age, sex, 
weight, ethnicity and employment and energy metabolism, these factors were shown 
to be significant in predicting Kt/TEE in a linear regression model. 
 
There is dearth of comparative clinical studies using these 3 parameters and hence, it 
is difficult to ascertain if one of these parameters is superior to others in providing 
dialysis dose based on metabolic needs of the individual. Daugirdas et al have argued 
that theoretically using REE, unlike BSA, will not result in substantial increase in 
dialysis dose to women 9. However, there is evidence to suggest that metabolic rate 
drives the glomerular filtration rate (GFR) 27. Also, GFR and metabolic rate scale to 
body mass with virtually the same exponent 28. Hence, metabolic rate i.e., REE could 
be a potential scaling parameter. Physical activity contributes to increased metabolism 
and thereby, higher metabolic waste production. It could be argued that TEE, 
incorporating both REE and physical activity, could be a better parameter more 
accurately reflecting total metabolic activity. As in the resting state, muscle 
metabolism is low but muscle mass is associated with physical activity. However, 
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these are theoretical arguments and there is need for comparative outcome-based 
studies employing standardised forms of these parameters to examine the effects of 
dialysis based on these different scaling factors. 
 
Our study has some limitations. This was a cross-sectional study with estimations of 
metabolic parameters carried out from a single anthropometric reading. However, we 
recruited 1500 patients and directly measured anthropometric values from each 
subject and not derived from historic medical records. We also recruited an ethnically 
diverse population and also did not restrict patient size, and as such, included patients 
with very different body composition. TEE was calculated from physical activity data 
collected through a recall questionnaire, which enquires about various activities in the 
preceding 4 weeks. As with any questionnaire methods, recall bias is a potential 
confounder in the accuracy of the data. Nevertheless, the physical activity level in our 
study cohort is in line with many previously published studies in haemodialysis 
patients. Although doubly labelled water is the gold standard method to measure TEE, 
the cost and cumbersome nature of studies using this method precludes it from being 
employed in large-scale epidemiological studies such as ours. We also used these 
anthropomorphic measurements to calculate total body water using the Watson 
equation, and subsequently used this value to estimate target Kt. Use of bioimpedance 
may have provided a more precise estimate of total body water as well as data on 
body composition. However in this multicenter study of 1500 patients, bioimpedance 
equipment was not available in all centres as is often the case in many centres in 
routine clinical practice. Hence all current clinical guidelines recommend using the 
Watson equation to calculate V.  As such our methodology followed currently 
published clinical guideline recommendations. 
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In conclusion, we have demonstrated that some of the metabolic parameters may be 
used to scale delivered dialysis dose and that V-based dialysis dosing used in current 
clinical practice risks under-dialysing women and small men. Our study findings 
additionally suggest a gender-, body size- and physical activity-specific V-based 
dosing or dosing based on these alternate metabolic parameters. Further outcome-
based studies will be useful in assessing the applicability of these alternate scaling 
parameters in routine clinical practice. 
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TABLE 1 
Demographic, anthropometric, dialysis and energy metabolism characteristics of 
1500 study patients. 
 
Values are expressed as mean ± SD. Proportions of categorical variables are 
expressed as percentages. REE: resting energy expenditure, EE: energy expenditure, 
TEE: total energy expenditure, MET: metabolic equivalent of task, BSA: body 
surface area, nPCR: normalised protein catabolic rate 
 All Patients 
(n = 1500) 
Males 
(n = 910) 
Females 
(n = 590) 
p-value 
Age (years) 62.9 ± 15.5 63.8 ± 15.6 61.6 ± 15.1 0.007 
Weight (kg) 75.2 ± 18.3 78.4 ± 17.3 70.4 ± 18.6 <0.001 
Height (cm) 165.9 ± 10.0 170.6 ± 8.2 158.7 ± 8.2 <0.001 
Ethnicity (South Asian: 
Black: White) 
418: 400: 
682 
249: 218: 
443 
169: 182: 
239 
0.003 
Body Mass Index (kg/m2) 27.3 ± 6.0 26.9 ± 5.3 27.9 ± 7 0.002 
High Comorbidity (%) 442 (29.5) 261 (28.7) 181 (30.7) 0.417 
Employed (%) 173 (11.5) 119 (13.1) 54 (9.2) 0.021 
Blood urea (mmol/L) 19.3 ± 5.7 19.6 ± 5.6 18.7 ± 5.8 0.004 
Dialysis Time (minutes) 225 ± 29 229 ± 29 219 ± 27 <0.001 
Blood flow rate (ml/min) 316 ± 41 322 ± 40 306 ± 40 <0.001 
Dialysate flow rate (ml/min) 592 ± 123 596 ± 126 587 ± 118 0.157 
Haemoglobin (g/dl) 10.9 ± 1.2 11.0 ± 1.2 10.8 ± 1.2 0.002 
Watson Volume (L) 37.5 ± 7.4 41.0 ± 6.6 32.2 ± 4.9 <0.001 
nPCR (g/kg/day) 1.03 ± 0.26 1.02 ± 0.26 1.03 ± 0.27 0.591 
Body Surface Area (m2) 1.87 ± 0.26 1.93 ± 0.24 1.77  ± 0.26 <0.001 
REE (kcal/day) 1545 ± 250 1621 ± 230 1429 ± 236 <0.001 
Mean daily MET 1.19 ± 0.13 1.20  ± 0.14 1.17 ± 0.10 <0.001 
Physical Activity EE 
(kcal/day) 
295 ± 221 327 ± 251 247 ± 154 <0.001 
TEE (kcal/day) 1841 ± 388 1948 ± 390 1676 ± 322 <0.001 
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TABLE 2 
Dialysis dose equivalent to a Kt/V of 1.2 expressed in terms of Kt, Kt/BSA, 
Kt/REE, Kt/TEE and Kt/nPCR.  
 NUMBER Kt 
(ml) 
Kt/BSA 
(ml/m2) 
Kt/REE 
(ml/kcal) 
Kt/TEE 
(ml/kcal) 
Kt/nPCR 
(ml/g/kg/day) 
All patients 1500 45,100 ± 8,900 24,000 ± 2,000 29.10 ± 2.17 24.72 ± 2.89 46,800 ± 15,600 
GENDER 
Male 910 49,300 ± 7,900 25,400 ± 1,200 30.34 ± 1.25 25.60 ± 2.73 51,100 ± 15,700 
Female 590 38,700 ± 5,900 21,900 ± 200 27.18 ± 1.87 23.36 ± 2.60 40,200 ± 12,900 
p-value 
(t-test) 
 <0.001 <0.001 <0.001 <0.001 <0.001 
WEIGHT Quartiles (kg) 
≤ 62.3 375 35,600 ± 3,900 22,800 ± 1,500 28.08 ± 2.11 24.08 ± 2.65 36,800 ± 10,300 
62.4 to 73 375 42,200 ± 3,900 23,800 ± 1,800 28.90 ± 1.86 24.50 ± 2.65 44,000 ± 13,000 
73.1 to 85.2 375 46,900 ± 4,400 24,300 ± 1,800 29.31 ± 1.96 24.80 ± 2.91 48,500 ± 12,800 
> 85.2 375 55,600 ± 7,400 25,100 ± 2,100 30.11 ± 2.24 25.48 ± 3.17 57,900 ± 17,200 
p-value 
(ANOVA) 
 <0.001 <0.001 <0.001 <0.001 <0.001 
AGE Quartiles  (years) 
≤ 52  375 46,900 ± 10,200 24,700 ± 2,500 28.15 ± 2.45 22.98 ± 3.13 46,700 ± 15,900 
52 to 65.3  375 46,000 ± 9,200 24,100 ± 2,000 27.60 ± 1.99 23.28 ± 2.60 47,800 ± 16,200 
65.4 to75.5  375 45,200 ± 8,500 23,800 ± 1,700 30.36 ± 1.43 26.22 ± 2.06 47,100 ± 16,000 
> 75.5 375 42,200 ± 6,600 23,400 ± 1,200 30.29 ± 0.86 26.38 ± 1.62 45,600 ± 13,900 
p-value 
(ANOVA) 
 <0.001 <0.001 <0.001 <0.001 0.244 
ETHNICITY 
South Asian 418 42,700 ± 8,100 23,900 ± 2,000 28.60 ± 2.26 24.16 ± 2.70 45,500 ± 13,900 
Black 400 46,500 ± 8,600 24,000 ± 2.100 28.87 ± 2.18 24.57 ± 2.93 47,900 ± 14,800 
White 682 45,800 ± 9,200 24,100 ± 1,900 29.54 ± 2.02 25.14 ± 2.92 47,000 ± 16,900 
p-value 
(ANOVA) 
 <0.001 0.244 <0.001 <0.001 0.074 
COMORBIDITY 
Low  1058 44,900 ± 8,900 24,100 ± 2,000 28.98 ± 2.19 24.40 ± 3.00 46,100 ± 15,100 
High 442 45,400 ± 8,800 23,800 ± 1,800 29.38 ± 2.11 25.47 ± 2.46 48,500 ± 16,400 
p-value 
(t-test) 
 0.412 <0.01 <0.001 <0.001 0.008 
EMPLOYMENT 
Working 173 48,600 ± 9100 24,900 ± 2,200 28.83 ± 2.18 20.61 ± 2.68 47,400 ± 14,500 
Not working 1327 44,600 ± 8700 23,900 ± 1,900 29.13 ± 2.17 25.25 ± 2.46 46,700 ± 15,700 
p-value 
(t-test) 
 <0.001 <0.001 0.086 <0.001 0.604 
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K is urea clearance, t is session length, BSA is body surface area, REE is resting 
energy expenditure, TEE is total energy expenditure, nPCR is normalised Protein 
Catabolic Rate. 
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TABLE 3 
Linear regression model of factors predicting Kt/BSA, Kt/REE, Kt/TEE and 
Kt/nPCR. The variables entered in the model were age, sex, weight, employment 
status, South Asian ethnicity (vs other ethnic groups) and Black ethnicity (vs other 
ethnic groups). 
 
Model 
Unstandardised 
Coefficients 
Standardised 
Coefficients 
(Beta) 
p-value 
B SE 
Kt/BSA (r2 = 0.917) 
Constant 22899.90 122.86  < 0.001 
Age (years) -39.37 1.03 -0.308 < 0.001 
Sex (Female vs. 
Male) 
3438.73 31.17 0.851 < 0.001 
Weight (kg) 22.65 0.85 0.21 < 0.001 
South Asian Ethnicity -119.72 36.59 -0.027 0.001 
Black Ethnicity -18.16 36.97 -0.004 0.623 
Kt/REE (r2 = 0.705) 
Constant 21.94 0.25  < 0.001 
Age (years) 0.055 0.002 0.390 < 0.001 
Sex (Female vs. 
Male) 
2.812 0.064 0.633 < 0.001 
Weight (kg) 0.028 0.002 0.237 < 0.001 
South Asian Ethnicity -0.235 0.076 -0.049 0.002 
Black Ethnicity 0.003 0.076 0.001 0.966 
Kt/TEE (r2 = 0.573) 
Constant 9.490 0.407  < 0.001 
Age (years) 0.064 0.003 0.344 < 0.001 
Sex (Female vs. 
Male) 
2.021 0.103 0.341 < 0.001 
Weight (kg) 0.029 0.003 0.186 < 0.001 
South Asian Ethnicity -0.321 0.121 -0.050 0.008 
Black Ethnicity 0.111 0.123 0.017 0.367 
Unemployed 4.140 0.160 0.457 < 0.001 
Kt/nPCR (r2 = 0.355) 
Constant 4843.18 2692.87  0.072 
Sex (Female vs. 
Male) 
7640.76 683.20 0.240 < 0.001 
Weight (kg) 431.87 18.56 0.507 < 0.001 
South Asian Ethnicity 1803.69 802.00 0.052 0.025 
Black Ethnicity 812.10 810.31 0.023 0.316 
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TITLES AND LEGENDS 
 
FIGURE 1 
Predicted delivered dialysis dose in relation to gender-specific mean body weight 
using (A) Kt  (B) Kt/BSA (C) Kt/REE and (D) Kt/TEE. 
 
 
 
 
 
Error bars represent mean and 95% confidence interval. 
 
Males (open circles) and females (filled circles). BSA – Body surface area, REE – 
Resting Energy Expenditure, TEE – Total Energy Expenditure 
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FIGURE 2 
Effect of age, ethnic group, comorbidity and employment status on Kt/TEE in males 
(open circles) and females (filled circles) 
 
Error bars represent mean and 95% confidence interval. 
 
 
